Laboratory Corporation of America’s planned acquisition of Sequenom Inc. has cleared antitrust review.
Burlington-based LabCorp said the Hart-Scott-Rodino Antitrust Improvements Act of 1976 waiting period has expired.

LabCorp and its subsidiary Savoy Acquisition Corp. will pay $2.40 a share or $371 million for San Diego-based Sequenom, which has Research Triangle Park operations. Sequenom offers non-invasive prenatal testing and other genetic tests.

Sequenom slashed its workforce by 20 percent this year, affecting the 60 person staff at its RTP facility.

The deal remains subject to customary closing conditions.

LabCorp (NYSE: LH) sells clinical and drug development services.